A detailed history of Rice Hall James & Associates, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 4,707 shares of ABBV stock, worth $839,681. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,707
Previous 4,727 0.42%
Holding current value
$839,681
Previous $810,000 14.69%
% of portfolio
0.05%
Previous 0.05%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$163.84 - $199.33 $3,276 - $3,986
-20 Reduced 0.42%
4,707 $929,000
Q1 2024

Apr 23, 2024

SELL
$159.82 - $182.1 $17,420 - $19,848
-109 Reduced 2.25%
4,727 $860,000
Q3 2023

Nov 02, 2023

SELL
$133.59 - $154.65 $6,679 - $7,732
-50 Reduced 1.02%
4,836 $720,000
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $9,938 - $12,367
-75 Reduced 1.51%
4,886 $658,000
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $2,892 - $3,330
-20 Reduced 0.4%
4,961 $790,000
Q4 2022

Jan 27, 2023

SELL
$138.31 - $165.87 $214,380 - $257,098
-1,550 Reduced 23.73%
4,981 $0
Q3 2022

Nov 01, 2022

SELL
$134.21 - $153.93 $13,421 - $15,393
-100 Reduced 1.51%
6,531 $877,000
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $6,330 - $8,048
-46 Reduced 0.69%
6,631 $1.02 Million
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $39,594 - $49,125
-300 Reduced 4.3%
6,677 $1.08 Million
Q3 2021

Nov 09, 2021

SELL
$106.4 - $120.78 $31,920 - $36,234
-300 Reduced 4.12%
6,977 $753,000
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $59,027 - $64,981
-577 Reduced 7.35%
7,277 $788,000
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $39,440 - $53,248
-490 Reduced 5.87%
7,854 $842,000
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $9,904 - $13,254
-135 Reduced 1.59%
8,344 $819,000
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $3,418 - $5,182
-53 Reduced 0.62%
8,479 $646,000
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $47,235 - $56,790
-750 Reduced 8.08%
8,532 $646,000
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $401,939 - $495,699
-5,163 Reduced 35.74%
9,282 $856,000
Q1 2018

Apr 25, 2018

SELL
$92.01 - $123.21 $64,407 - $86,247
-700 Reduced 4.62%
14,445 $1.37 Million
Q4 2017

Jan 23, 2018

SELL
$89.56 - $98.21 $61,975 - $67,961
-692 Reduced 4.37%
15,145 $1.47 Million
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $1.11 Million - $1.41 Million
15,837
15,837 $1.41 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.